Filing Details
- Accession Number:
- 0001213900-23-019384
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-13 08:00:20
- Reporting Period:
- 2023-03-10
- Accepted Time:
- 2023-03-13 08:00:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1733413 | Tff Pharmaceuticals Inc. | TFFP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1555563 | F Harlan Weisman | 1751 River Run, Suite 400 Fort Worth TX 76107 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-10 | 150,000 | $0.88 | 214,615 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported shares were purchased in the open market in one transaction at the price of $0.8789.
Billionaire Hedge Funds
